News

If you wish to view this page in your preferred RSS reader, you can access the RSS feed here.

 

Cancer Research UK launched an international study today, to answer the final questions before aspirin could be recommended to reduce cancer risk. Studies have estimated that widespread use of low-dose aspirin could lead to a 10% drop in the number of people dying from some cancers, but for every 17 lives saved by preventing cancer or heart attacks there would be two deaths ca ...

Add-Aspirin is now open at 9 centres in India: Tata Memorial Hospital, Mumbai Chennai Breast Centre Jehangir Clinical Development Centre, Pune Tata Medical Centre, Kolkata Meditrina Institute of Medical Sciences, Nashik Shatabdi Hospital, Nagpur Vikram & Fortis Hospital, Bengaluru Cancer Institute (WIA), Chennai Regional Cancer Centre, Trivandrum These centres ...

New study reports: “No benefit of Celecoxib in Breast Cancer Patients”A recent study looking at the use of the non-steroidal anti-inflammatory drug (NSAID), celecoxib, in participants who have had surgery for breast cancer, has shown no improvement in survival compared with a placebo (dummy drug). This research was performed on 2639 patients who had undergone surgery (sometim ...

Please note the Randomisation phone line will be closed from 5pm on Friday 22nd December and will reopen at 9am on 2nd January 2018.

The last date for sending translational samples to biobanks will be 30th December 2017.

Wales Cancer Bank will re-open on Tuesday 2nd Jan 2018 and Tayside Tissue Bank will reopen on Wednesday 3rd Jan 2018.

An Add-Aspirin Investigator Meeting will be held on Monday 6th November alongside the NCRI Cancer Conference in Liverpool. You do not need to be registered for the conference in order to attend the meeting.